Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Long-Term Deferred Tax (2016 - 2025)

Conmed's Long-Term Deferred Tax history spans 16 years, with the latest figure at $13.3 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 20.24% year-over-year to $13.3 million; the TTM value through Dec 2025 reached $13.3 million, up 20.24%, while the annual FY2025 figure was $13.3 million, 20.24% up from the prior year.
  • Long-Term Deferred Tax reached $13.3 million in Q4 2025 per CNMD's latest filing, up from $11.1 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $13.3 million in Q4 2025 to a low of $9.6 million in Q4 2022.
  • Average Long-Term Deferred Tax over 5 years is $11.0 million, with a median of $11.1 million recorded in 2024.
  • Peak YoY movement for Long-Term Deferred Tax: soared 41.14% in 2021, then decreased 1.27% in 2024.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $9.7 million in 2021, then decreased by 0.07% to $9.6 million in 2022, then increased by 16.18% to $11.2 million in 2023, then dropped by 1.27% to $11.1 million in 2024, then increased by 20.24% to $13.3 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Long-Term Deferred Tax are $13.3 million (Q4 2025), $11.1 million (Q4 2024), and $11.2 million (Q4 2023).